Apnimed to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, today announced that Apnimed will participate in the Jefferies Healthcare Conference taking place June 8-10, 2022, an...
Source: pharmiweb.com